Skip to main content

Shimadzu Visits YMC America

YMC America was pleased to recently host representatives from Shimadzu at our facility in Devens, MA. The visit provided a valuable opportunity for strategic discussion focused on potential cooperative programs between our organizations.

Our CEO, Mark Dyment, met with the President/CEO of Shimadzu, Yasunori Yamamoto, the President of Shimadzu Scientific Instruments, Patrick Fromal, and the extended team to explore areas of synergy and future collaboration. Both YMC America and Shimadzu share a commitment to advancing scientific discovery through high-quality instrumentation and consumables.

We look forward to the potential outcomes of these productive conversations and the continued strengthening of our industry relationship.

Posted on April 11, 2025.

Related Posts

September 4, 2026

YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers

YMC America will be the First U.S.-Based Supplier of ASME U-Stamped DAC Columns. The company’s DAC columns support pharmaceutical and biopharmaceutical customers from process development through commercial production. Systems are used in laboratory, pilot, and production-scale chromatography applications, including purification processes for peptides, oligonucleotides, and small-molecule APIs.

September 10, 2026

Analytical Technologies for Therapeutic Peptides

Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.

September 9, 2026

Tecnologias Analíticas para Peptídeos Terapêuticos- Portuguese

Os peptídeos terapêuticos são uma classe emergente de insumos farmacêuticos ativos que, juntamente com outras classes de bioprodutos, vêm despertando grande interesse devido às suas vantagens únicas.

Designed and developed by